Tianshirikang: Subsidiary Tolasemi Injection Receives Drug Registration Certificate.

Tianshirli announced on May 28th that its wholly-owned subsidiary, Jiangsu Tianshirli Deyi Pharmaceutical Co., Ltd., has obtained the "Drug Registration Certificate" issued by the National Medical Products Administration for Torasemide Injection. Torasemide Injection is suitable for patients with congestive heart failure who require rapid diuresis or cannot take oral diuretics, as well as those with ascites due to liver cirrhosis or edema caused by kidney disease.